Cubist Systematic Strategies’s Sana Biotechnology SANA Stock Holding History

Cubist Systematic Strategies’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-46,653	Closed	-$194K	–	3839
2024 Q3	$194K	Buy	+46,653	New	+$245K	﹤0.01%	2580
2023 Q2	–	Sell	-20,294	Closed	-$66.4K	–	4234
2023 Q1	$66.4K	Sell	20,294 -78,879	-80%	-$315K	﹤0.01%	3522
2022 Q4	$392K	Sell	99,173 -86,821	-47%	-$425K	﹤0.01%	3185
2022 Q3	$1.12M	Buy	185,994 +157,501	+553%	+$1.14M	0.01%	2533
2022 Q2	$183K	Sell	28,493 -25,483	-47%	-$162K	﹤0.01%	3749
2022 Q1	$446K	Buy	53,976 +40,476	+300%	+$327K	﹤0.01%	2610
2021 Q4	$209K	Buy	+13,500	New	+$260K	﹤0.01%	3010

Other funds holding SANA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return